Transplantation of ABO A2 kidneys into O recipients: Do IgM anti-A1 titers matter?

Clinical Transplantation

Volumn 29, Issue 4, 2015, Pages 379-382

  Tierney, Joshua ^a   Shaffer, David ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

A2 kidney allocation; ABO incompatible; Anti A titers; Kidney transplantation

Indexed keywords

ALEMTUZUMAB; COMPLEMENT COMPONENT C4D; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; ALLOANTIBODY; BLOOD GROUP ABO SYSTEM;

ACUTE GRAFT REJECTION; ACUTE VASCULAR REJECTION; ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD GROUP A; BLOOD GROUP A2; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP O; CLINICAL ARTICLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MIDDLE AGED; NEPHRECTOMY; OUTCOME ASSESSMENT; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; THROMBOTIC THROMBOCYTOPENIC PURPURA; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; CLINICAL TRIAL; FOLLOW UP; GRAFT SURVIVAL; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; PROGNOSIS;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; BLOOD GROUP INCOMPATIBILITY; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84927909721     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12527     Document Type: Article

References (11)

1. Breimer ME, Molne J, Norden G, Rydberg L, Thiel G, Svalander CT. Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. Transplantation 2006: 82: 479.
2. Breimer ME, Samuelsson BE. The specific distribution of glycolipid-based blood group A antigens in human kidney related to A1/A2, Lewis and secretor status of single individuals. Transplantation 1986: 42: 86.
3. Norman DJ, Prather JC, Alkhunaizi AM, deMattos AM, Golconda M, Barry JM. Use of A(2) kidneys for B and O kidney transplant recipients: report of a series of patients transplanted at a single center spanning a decade. Transplant Proc 2001: 33: 3327.
4. Gloor JM, Lager DJ, Morre SB et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003: 75: 971.
5. Sorensen JB, Grant WJ, Belnap LP, Stinson J, Fuller TC. Transplantation of ABO group A2 kidneys from living donors into group O and B recipients. Am J Transplant 2001: 1: 296.
6. Bryan CF, Winklhofer FT, Murillo D et al. Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. Transplantation 2005: 80: 75.
7. Nelson PW, Helling TS, Shield CF, Beck M, Bryan CF. Current experience with renal transplantation across the ABO barrier. Am J Surg 1992: 164: 541.
8. Nelson PW, Landreneau MD, Luger AM et al. Ten-year experience in transplantation of A2 kidneys into B and O recipients. Transplantation 1998: 65: 256.
9. www.UNOS.org, UNOS policy 3.5.5.4
10. Ishida H, Tanabe K, Furusawa M et al. Efficacy of IgM anti-blood type antibody monitoring by enzyme-linked immunosorbent assay after renal transplantation across the blood barrier: high-dose immunoglobulin administration blocks IgM rather than IgG anti-blood type antibodies. Transplant Proc 2004: 36: 2178.
11. Hanto DW, Brunt EM, Goss JA, Cole BR. Accelerated acute rejection of an A2 renal allograft in an O recipient: association with an increase in anti-A2 antibodies. Transplantation 1993: 56: 1580.